News

Aleo BME, a leading biomaterials innovator, announced receiving 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's liquid bandage product, ElaSkin™. The 510(k) clearance allows the company to market and sell the product for use by both healthcare professionals and general consumers. Read more...

Aleo BME's breakthrough in nerve repair and regeneration is featured in Penn State's Innovation News. The article, titled "Aleo BME, Inc. Makes Breakthrough in Nerve Repair and Regeneration", is a look into the team behind Aleo BME and the story of their success. Read more...

Aleo BME's founding team graduates from a 10-week TechCelerator program. These programs, run by Ben Franklin Technology Partners, are aimed at helping technology start ups in the Central and Northern Pennsylvania region attain the skills necessary not only to run a business, but also to market themselves. Read more...

Aleo BME, Inc. receives seed funding to get off the ground with its innovation biomaterials technology.